Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

Recent advances in DNA sequencing, combined with new stem cell research approaches, have allowed an international group of scientists to identify a previously unrecognized form of diabetes that ...

Amazon ( AMZN +0.26%) continues to underscore the strength of its business and deliver fantastic growth for long-term ...

From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics ...

Taking this class absolutely transformed what I thought about science and how I thought about myself as a student,” Nellie ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Imagine if you could fix a spelling mistake in a long document with just one click. Now, imagine doing the same with the genetic code of a plant or even a human cell. That’s ...

A lot of this year’s health news was exhausting and demoralizing, as the Trump administration weakened scientific agencies ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

These stocks have promising assets in their portfolios that could help make their valuations soar in the future.

Despite being one of the rockiest years yet for science — marked by millions of dollars in funding cuts and controversial ...

VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.